![Jaime Contreras](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jaime Contreras
Direktor/Vorstandsmitglied bei
Covira Surgical, Inc.
Profil
Jaime Contreras is currently the Director at Covira Surgical, Inc. Prior to this, she was the Director at Abbott GmbH (Germany) and Vice President-Diagnostic Commercial Operations at Abbott Laboratories from 2000 to 2012.
Aktive Positionen von Jaime Contreras
| Unternehmen | Position | Beginn |
|---|---|---|
Covira Surgical, Inc.
 Covira Surgical, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the development of drugs that modulate the biological activity of the gut microbiome's resident bacteria | Direktor/Vorstandsmitglied | 01.01.2022 |
Ehemalige bekannte Positionen von Jaime Contreras
| Unternehmen | Position | Ende |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Abbott GmbH (Germany)
 Abbott GmbH (Germany) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical, diagnostic, nutritional, and hospital products | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Abbott GmbH (Germany)
Abbott GmbH (Germany) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical, diagnostic, nutritional, and hospital products | Health Technology |
Covira Surgical, Inc.
Covira Surgical, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the development of drugs that modulate the biological activity of the gut microbiome's resident bacteria | Commercial Services |
Wählen Sie MarketScreener 
